[1] MARTHE M. VANDEPUTTE. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass[J]. Archives of Toxicology, 2022, 96 6: 1865-1880. DOI:
10.1007/s00204-022-03294-2[2] LAURA B KOZELL. Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for Toxicity.[J]. Journal of Pharmacology and Experimental Therapeutics, 2024: 219-228. DOI:
10.1124/jpet.123.002052[3] MENG-HUA M. TSAI, LEI SHI* In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling[J]. ACS Chemical Neuroscience, 2024, 15 4: 854-867. DOI:
10.1021/acschemneuro.3c00750